86 related articles for article (PubMed ID: 12443567)
1. Prevalence of PSA testing and effect of clinical indications on patterns of PSA testing in a population-based sample of Alberta men.
McGregor SE; Bryant HE; Brant RF; Corbett PJ
Chronic Dis Can; 2002; 23(3):111-9. PubMed ID: 12443567
[TBL] [Abstract][Full Text] [Related]
2. Self-reported prostate cancer screening in Austria.
Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G
J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656
[TBL] [Abstract][Full Text] [Related]
3. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
Pinnock CB; Weller DP; Marshall VR
Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698
[TBL] [Abstract][Full Text] [Related]
4. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
5. Public awareness of prostate cancer and the prostate-specific antigen test.
Mainous AG; Hagen MD
Cancer Pract; 1994; 2(3):217-21. PubMed ID: 7519944
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
McDavid K; Melnik TA; Derderian H
Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
8. Predictors of prostate cancer screening among health fair participants.
Chiu BC; Anderson JR; Corbin D
Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
[TBL] [Abstract][Full Text] [Related]
9. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
[TBL] [Abstract][Full Text] [Related]
10. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
11. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
[TBL] [Abstract][Full Text] [Related]
12. PSA testing in office-based clinics: are we testing as much as we think?
González HM; West B; Underwood W
J Am Coll Surg; 2005 Dec; 201(6):906-12. PubMed ID: 16310694
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
Dyche DJ; Ness J; West M; Allareddy V; Konety BR
J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807
[TBL] [Abstract][Full Text] [Related]
14. Trends in prostate-specific antigen testing from 1995 through 2004.
Farwell WR; Linder JA; Jha AK
Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
16. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
17. Screening for prostate cancer: updated experience from the Tyrol study.
Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.
Pilebro B; Johansson R; Damber L; Damber JE; Stattin P
Scand J Urol Nephrol; 2003; 37(3):210-2. PubMed ID: 12775278
[TBL] [Abstract][Full Text] [Related]
20. Evidence of prostate cancer screening in a UK region.
Gavin A; McCarron P; Middleton RJ; Savage G; Catney D; O'Reilly D; Keane PF; Murray LJ
BJU Int; 2004 Apr; 93(6):730-4. PubMed ID: 15049981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
